<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39391317</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Exploring common pathogenic association between Epstein Barr virus infection and long-COVID by integrating RNA-Seq and molecular dynamics simulations.</ArticleTitle><Pagination><StartPage>1435170</StartPage><MedlinePgn>1435170</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1435170</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1435170</ELocationID><Abstract><AbstractText>The term "Long-COVID" (LC) is characterized by the aftereffects of COVID-19 infection. Various studies have suggested that Epstein-Barr virus (EBV) reactivation is among the significant reported causes of LC. However, there is a lack of in-depth research that could largely explore the pathogenic mechanism and pinpoint the key genes in the EBV and LC context. This study mainly aimed to predict the potential disease-associated common genes between EBV reactivation and LC condition using next-generation sequencing (NGS) data and reported naturally occurring biomolecules as inhibitors. We applied the bulk RNA-Seq from LC and EBV-infected peripheral blood mononuclear cells (PBMCs), identified the differentially expressed genes (DEGs) and the Protein-Protein interaction (PPI) network using the STRING database, identified hub genes using the cytoscape plugins CytoHubba and MCODE, and performed enrichment analysis using ClueGO. The interaction analysis of a hub gene was performed against naturally occurring bioflavonoid molecules using molecular docking and the molecular dynamics (MD) simulation method. Out of 357 common genes, 22 genes (CCL2, CCL20, CDCA2, CEP55, CHI3L1, CKAP2L, DEPDC1, DIAPH3, DLGAP5, E2F8, FGF1, NEK2, PBK, TOP2A, CCL3, CXCL8, DEPDC1, IL6, RETN, MMP2, LCN2, and OLR1) were classified as hub genes, and the remaining ones were classified as neighboring genes. Enrichment analysis showed the role of hub genes in various pathways such as immune-signaling pathways, including JAK-STAT signaling, interleukin signaling, protein kinase signaling, and toll-like receptor pathways associated with the symptoms reported in the LC condition. ZNF and MYBL TF-family were predicted as abundant TFs controlling hub genes' transcriptional machinery. Furthermore, OLR1 (PDB: 7XMP) showed stable interactions with the five shortlisted refined naturally occurring bioflavonoids, i.e., apigenin, amentoflavone, ilexgenin A, myricetin, and orientin compounds. The total binding energy pattern was observed, with amentoflavone being the top docked molecule (with a binding affinity of -8.3 kcal/mol) with the lowest total binding energy of -18.48 kcal/mol. In conclusion, our research has predicted the hub genes, their molecular pathways, and the potential inhibitors between EBV and LC potential pathogenic association. The <i>in vivo</i> or <i>in vitro</i> experimental methods could be utilized to functionally validate our findings, which would be helpful to cure LC or to prevent EBV reactivation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Kanwal and Zhang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kanwal</LastName><ForeName>Ayesha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>MOE Key Laboratory for Cellular Dynamics and Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhiyong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>MOE Key Laboratory for Cellular Dynamics and Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physics, University of Science and Technology of China, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020031" MajorTopicYN="Y">Epstein-Barr Virus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004854" MajorTopicYN="Y">Herpesvirus 4, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056004" MajorTopicYN="Y">Molecular Dynamics Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000081246" MajorTopicYN="Y">RNA-Seq</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060066" MajorTopicYN="Y">Protein Interaction Maps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EBV-reactivation</Keyword><Keyword MajorTopicYN="N">RNA-Seq</Keyword><Keyword MajorTopicYN="N">bioflavonoids</Keyword><Keyword MajorTopicYN="N">hub-genes</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">molecular docking</Keyword><Keyword MajorTopicYN="N">molecular dynamics simulation</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>10</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>10</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>11</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39391317</ArticleId><ArticleId IdType="pmc">PMC11464307</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1435170</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Coronavirus disease (COVID-19) situation Reports (n.). Available online at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports (Accessed February 18, 2024).</Citation></Reference><Reference><Citation>Eythorsson E, Helgason D, Ingvarsson RF, Bjornsson HK, Olafsdottir LB, Bjarnadottir V, et al. . Clinical spectrum of coronavirus disease 2019 in Iceland: population based cohort study. BMJ. (2020) 371. doi:&#xa0;10.1136/BMJ.M4529</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.M4529</ArticleId><ArticleId IdType="pmc">PMC7708618</ArticleId><ArticleId IdType="pubmed">33268329</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier JC, Million M, Gautret P, Colson P, Cortaredona S, Giraud-Gatineau A, et al. . Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. (2020) 36:101791. doi:&#xa0;10.1016/J.TMAID.2020.101791</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.TMAID.2020.101791</ArticleId><ArticleId IdType="pmc">PMC7315163</ArticleId><ArticleId IdType="pubmed">32593867</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltezou HC, Raftopoulos V, Vorou R, Papadima K, Mellou K, Spanakis N, et al. . Association between upper respiratory tract viral load, comorbidities, disease severity, and outcome of patients with SARS-coV-2 infection. J Infect Dis. (2021) 223:1132&#x2013;8. doi:&#xa0;10.1093/INFDIS/JIAA804</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/INFDIS/JIAA804</ArticleId><ArticleId IdType="pmc">PMC7798974</ArticleId><ArticleId IdType="pubmed">33388780</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S, Rosell A, Phillipson M, Mangsbo SM, Nilsson P, Hober S, et al. . Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers. JAMA. (2021) 325:2015&#x2013;6. doi:&#xa0;10.1001/JAMA.2021.5612</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMA.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavli A, Theodoridou M, Maltezou HC. Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Arch Med Res. (2021) 52:575. doi:&#xa0;10.1016/J.ARCMED.2021.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ARCMED.2021.03.010</ArticleId><ArticleId IdType="pmc">PMC8093949</ArticleId><ArticleId IdType="pubmed">33962805</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones OY, Yeralan S. Is long COVID a state of systemic pericyte disarray? J Clin Med. (2022) 11:572. doi:&#xa0;10.3390/JCM11030572</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/JCM11030572</ArticleId><ArticleId IdType="pmc">PMC8836446</ArticleId><ArticleId IdType="pubmed">35160024</ArticleId></ArticleIdList></Reference><Reference><Citation>Alpert O, Begun L, Garren P, Solhkhah R. Cytokine storm induced new onset depression in patients with COVID-19. A new look into the association between depression and cytokines -two case reports. Brain Behav Immun Health. (2020) 9:100173. doi:&#xa0;10.1016/J.BBIH.2020.100173</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBIH.2020.100173</ArticleId><ArticleId IdType="pmc">PMC7606074</ArticleId><ArticleId IdType="pubmed">33163979</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Guijarro C, Plaza-Canteli S, Hern&#xe1;ndez-Barrera V, Torres-Macho J. Prevalence of post-COVID-19 cough one year after SARS-coV-2 infection: A multicenter study. Lung. (2021) 199:249. doi:&#xa0;10.1007/S00408-021-00450-W</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00408-021-00450-W</ArticleId><ArticleId IdType="pmc">PMC8124095</ArticleId><ArticleId IdType="pubmed">33993321</ArticleId></ArticleIdList></Reference><Reference><Citation>McCorkell L, Assaf GS, Davis HE, Wei H, Akrami A. Patient-Led Research Collaborative: embedding patients in the Long COVID narrative. Pain Rep. (2021) 6:e913. doi:&#xa0;10.1097/PR9.0000000000000913</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000000913</ArticleId><ArticleId IdType="pmc">PMC8112577</ArticleId><ArticleId IdType="pubmed">33987484</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin L, Savale L, Pham T, Colle R, Figueiredo S, Harrois A, et al. . Four-month clinical status of a cohort of patients after hospitalization for COVID-19. JAMA. (2021) 325:1525&#x2013;34. doi:&#xa0;10.1001/JAMA.2021.3331</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMA.2021.3331</ArticleId><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L, Baca S, Saydah S, Boehmer TK, Adjei S, Gray S, et al. . Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years &#x2014; United states, march 2020&#x2013;november 2021. MMWR Morb Mortal Wkly Rep. (2022) 71:713&#x2013;7. doi:&#xa0;10.15585/MMWR.MM7121E1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/MMWR.MM7121E1</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. . Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. (2022) 101:93&#x2013;135. doi:&#xa0;10.1016/J.BBI.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BBI.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>
Patients diagnosed with post-COVID conditions: an analysis of private healthcare claims using the official ICD-10 diagnostic code - Digital Collections - National Library of Medicine (n.). Available online at: https://collections.nlm.nih.gov/catalog/nlm:nlmuid-9918504887106676-pdf (Accessed February 18, 2024).</Citation></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. (2022) 28:583&#x2013;90. doi:&#xa0;10.1038/S41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. (2022) 10:311&#x2013;21. doi:&#xa0;10.1016/S2213-8587(22)00044-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini DM, Brunjes DL, Lala A, Trivieri MG, Contreras JP, Natelson BH. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail. (2021) 9:927&#x2013;37. doi:&#xa0;10.1016/J.JCHF.2021.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JCHF.2021.10.002</ArticleId><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Demko ZO, Yu T, Mullapudi SK, Heslin MGV, Dorsey CA, Payton CB, et al. . Post-acute sequelae of SARS-CoV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection. medRxiv. (2022) 2022:8.08.22278543. doi:&#xa0;10.1101/2022.08.08.22278543</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.08.22278543</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Hanitsch LG, Zoller T, et al. . A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. (2022) 13:1&#x2013;13. doi:&#xa0;10.1038/s41467-022-32507-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen NW, Stiles LE, Shaik R, Schneider L, Muppidi S, Tsui CT, et al. . Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults. Front Neurol. (2022) 13:1012668. doi:&#xa0;10.3389/FNEUR.2022.1012668</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNEUR.2022.1012668</ArticleId><ArticleId IdType="pmc">PMC9639503</ArticleId><ArticleId IdType="pubmed">36353127</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. (2021) 9:129. doi:&#xa0;10.1016/S2213-2600(21)00031-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Sivan M, Delaney B, Evans R, Milne R. Long covid&#x2014;an update for primary care. BMJ. (2022) 378. doi:&#xa0;10.1136/BMJ-2022-072117</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ-2022-072117</ArticleId><ArticleId IdType="pubmed">36137612</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, et al. . Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. (2023) 76:E487&#x2013;90. doi:&#xa0;10.1093/CID/CIAC722</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/CID/CIAC722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. (2021) 12:698169/BIBTEX. doi:&#xa0;10.3389/FMICB.2021.698169/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMICB.2021.698169/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S, Ibn Hadj Amor H, Jdidi J, Torjmen S, Kraiem S, Hammami R, et al. . Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-endCOV study. Front Cardiovasc Med. (2021) 8:745758. doi:&#xa0;10.3389/FCVM.2021.745758</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FCVM.2021.745758</ArticleId><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR, et al. . Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC). Cardiovasc Diabetol. (2022) 21:1&#x2013;17. doi:&#xa0;10.1186/S12933-022-01579-5/FIGURES/12</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12933-022-01579-5/FIGURES/12</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko S, Kril I, Nadizhko O, Matsyura O, Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol Int. (2022) 42:1523&#x2013;30. doi:&#xa0;10.1007/S00296-022-05146-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00296-022-05146-9</ArticleId><ArticleId IdType="pmc">PMC9159383</ArticleId><ArticleId IdType="pubmed">35650445</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A, Vojdani E, Saidara E, Maes M. Persistent SARS-coV-2 infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in long COVID. Viruses. (2023) 15:400. doi:&#xa0;10.3390/V15020400</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/V15020400</ArticleId><ArticleId IdType="pmc">PMC9967513</ArticleId><ArticleId IdType="pubmed">36851614</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. . Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. (2022) 185:881&#x2013;895.e20. doi:&#xa0;10.1016/J.CELL.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELL.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Aloisi F, Giovannoni G, Salvetti M. Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy. Lancet Neurol. (2023) 22:338&#x2013;49. doi:&#xa0;10.1016/S1474-4422(22)00471-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(22)00471-9</ArticleId><ArticleId IdType="pubmed">36764322</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K, M&#xfc;nz C, Cohen JI, Ascherio A. Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nat Rev Neurol. (2023) 19:160&#x2013;71. doi:&#xa0;10.1038/S41582-023-00775-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41582-023-00775-5</ArticleId><ArticleId IdType="pubmed">36759741</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Song J, Liu H, Zheng H, Chen C. Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients. Sci Rep. (2021) 11:10902. doi:&#xa0;10.1038/S41598-021-90351-Y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41598-021-90351-Y</ArticleId><ArticleId IdType="pmc">PMC8149409</ArticleId><ArticleId IdType="pubmed">34035353</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to epstein-barr virus reactivation. Pathogens. (2021) 10:763. doi:&#xa0;10.3390/PATHOGENS10060763</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/PATHOGENS10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganelli R. Resurrecting epstein-barr virus. Pathogens. (2022) 11:772. doi:&#xa0;10.3390/PATHOGENS11070772</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/PATHOGENS11070772</ArticleId><ArticleId IdType="pmc">PMC9318925</ArticleId><ArticleId IdType="pubmed">35890017</ArticleId></ArticleIdList></Reference><Reference><Citation>von der Th&#xfc;sen J, van der Eerden M. Histopathology and genetic susceptibility in COVID-19 pneumonia. Eur J Clin Invest. (2020) 50:e13259. doi:&#xa0;10.1111/ECI.13259</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ECI.13259</ArticleId><ArticleId IdType="pmc">PMC7267318</ArticleId><ArticleId IdType="pubmed">32353898</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, Leavy OC, Richardson M, Elneima O, McAuley HJC, Shikotra A, et al. . Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. (2022) 10:761&#x2013;75. doi:&#xa0;10.1016/S2213-2600(22)00127-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapola H, de Bastiani MA, Duarte MM, Freitas MB, Schuster JS, de Vargas DM, et al. . A comparative study of COVID-19 transcriptional signatures between clinical samples and preclinical cell models in the search for disease master regulators and drug repositioning candidates. Virus Res. (2023) 326:199053. doi:&#xa0;10.1016/J.VIRUSRES.2023.199053</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.VIRUSRES.2023.199053</ArticleId><ArticleId IdType="pmc">PMC9877318</ArticleId><ArticleId IdType="pubmed">36709793</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Ding L, Gong Y, Zhao J, Xin G, Zhou R, et al. . Identification of hub genes associated with the pathogenesis of diffuse large B-cell lymphoma subtype one characterized by host response via integrated bioinformatic analyses. PeerJ. (2020) 8:e10269. doi:&#xa0;10.7717/PEERJ.10269/SUPP-11</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/PEERJ.10269/SUPP-11</ArticleId><ArticleId IdType="pmc">PMC7682441</ArticleId><ArticleId IdType="pubmed">33240622</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Xia S, Sui H, Shi X, Huang B, Wang T. Identification of hub genes associated with COVID-19 and idiopathic pulmonary fibrosis by integrated bioinformatics analysis. PloS One. (2022) 17:e0262737. doi:&#xa0;10.1371/JOURNAL.PONE.0262737</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0262737</ArticleId><ArticleId IdType="pmc">PMC8769324</ArticleId><ArticleId IdType="pubmed">35045126</ArticleId></ArticleIdList></Reference><Reference><Citation>Noor F, Ashfaq UA, Bakar A, ul Haq W, Allemailem KS, Alharbi BF, et al. . Discovering common pathogenic processes between COVID-19 and HFRS by integrating RNA-seq differential expression analysis with machine learning. Front Microbiol. (2023) 14:1175844/BIBTEX. doi:&#xa0;10.3389/FMICB.2023.1175844/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMICB.2023.1175844/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC10208410</ArticleId><ArticleId IdType="pubmed">37234545</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao P, Zhen H, Zhao H, Huang Y, Cao B. Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets. J Transl Med. (2023) 21:1&#x2013;16. doi:&#xa0;10.1186/S12967-023-04029-2/FIGURES/10</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12967-023-04029-2/FIGURES/10</ArticleId><ArticleId IdType="pmc">PMC9987056</ArticleId><ArticleId IdType="pubmed">36879254</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K, Peluso MJ, Luo X, Thomas R, Shin MG, Neidleman J, et al. . Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat Immunol. (2024) 25:218&#x2013;25. doi:&#xa0;10.1038/s41590-023-01724-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01724-6</ArticleId><ArticleId IdType="pmc">PMC10834368</ArticleId><ArticleId IdType="pubmed">38212464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma N, Lu J, Pei Y, Robertson ES. Transcriptome reprogramming of Epstein-Barr virus infected epithelial and B cells reveals distinct host-virus interaction profiles. Cell Death Dis. (2022) 13:894. doi:&#xa0;10.1038/S41419-022-05327-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41419-022-05327-1</ArticleId><ArticleId IdType="pmc">PMC9588026</ArticleId><ArticleId IdType="pubmed">36272970</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert M, Lindgreen S, Orlando L. AdapterRemoval v2: rapid adapter trimming, identification, and read merging. BMC Res Notes. (2016) 9:1&#x2013;7. doi:&#xa0;10.1186/S13104-016-1900-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13104-016-1900-2</ArticleId><ArticleId IdType="pmc">PMC4751634</ArticleId><ArticleId IdType="pubmed">26868221</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. . STAR: ultrafast universal RNA-seq aligner. Bioinformatics. (2013) 29:15. doi:&#xa0;10.1093/BIOINFORMATICS/BTS635</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/BIOINFORMATICS/BTS635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. . The sequence alignment/map format and SAMtools. Bioinformatics. (2009) 25:2078&#x2013;9. doi:&#xa0;10.1093/BIOINFORMATICS/BTP352</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/BIOINFORMATICS/BTP352</ArticleId><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. (2014) 30:923&#x2013;30. doi:&#xa0;10.1093/BIOINFORMATICS/BTT656</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/BIOINFORMATICS/BTT656</ArticleId><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. (2014) 15:1&#x2013;21. doi:&#xa0;10.1186/S13059-014-0550-8/FIGURES/9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13059-014-0550-8/FIGURES/9</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge SX, Jung D, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. (2020) 36:2628&#x2013;9. doi:&#xa0;10.1093/BIOINFORMATICS/BTZ931</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/BIOINFORMATICS/BTZ931</ArticleId><ArticleId IdType="pmc">PMC7178415</ArticleId><ArticleId IdType="pubmed">31882993</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. . The STRING database in 2023: protein&#x2013;protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. (2023) 51:D638&#x2013;46. doi:&#xa0;10.1093/NAR/GKAC1000</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/NAR/GKAC1000</ArticleId><ArticleId IdType="pmc">PMC9825434</ArticleId><ArticleId IdType="pubmed">36370105</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu D, Lim J, Wang X, Liang F, Xiao G. Enhanced construction of gene regulatory networks using hub gene information. BMC Bioinf. (2017) 18:1&#x2013;20. doi:&#xa0;10.1186/S12859-017-1576-1/FIGURES/7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12859-017-1576-1/FIGURES/7</ArticleId><ArticleId IdType="pmc">PMC5364645</ArticleId><ArticleId IdType="pubmed">28335719</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. (2014) 8:1&#x2013;7. doi:&#xa0;10.1186/1752-0509-8-S4-S11/TABLES/4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1752-0509-8-S4-S11/TABLES/4</ArticleId><ArticleId IdType="pmc">PMC4290687</ArticleId><ArticleId IdType="pubmed">25521941</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. . Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. (2003) 13:2498&#x2013;504. doi:&#xa0;10.1101/GR.1239303</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/GR.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Bader GD, Hogue CWV. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinf. (2003) 4:1&#x2013;27. doi:&#xa0;10.1186/1471-2105-4-2/FIGURES/12</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-4-2/FIGURES/12</ArticleId><ArticleId IdType="pmc">PMC149346</ArticleId><ArticleId IdType="pubmed">12525261</ArticleId></ArticleIdList></Reference><Reference><Citation>Combadi&#xe8;re B, Adam L, Guillou N, Quentric P, Rosenbaum P, Dorgham K, et al. . LOX-1-expressing immature neutrophils identify critically-ill COVID-19 patients at risk of thrombotic complications. Front Immunol. (2021) 12:752612/BIBTEX. doi:&#xa0;10.3389/FIMMU.2021.752612/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2021.752612/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8488276</ArticleId><ArticleId IdType="pubmed">34616409</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. . Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. (2016) 44:W90. doi:&#xa0;10.1093/NAR/GKW377</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/NAR/GKW377</ArticleId><ArticleId IdType="pmc">PMC4987924</ArticleId><ArticleId IdType="pubmed">27141961</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. . UCSF Chimera&#x2013;a visualization system for exploratory research and analysis. J Comput Chem. (2004) 25:1605&#x2013;12. doi:&#xa0;10.1002/JCC.20084</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JCC.20084</ArticleId><ArticleId IdType="pubmed">15264254</ArticleId></ArticleIdList></Reference><Reference><Citation>Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol. (2015) 1263:243&#x2013;50. doi:&#xa0;10.1007/978-1-4939-2269-7_19</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-2269-7_19</ArticleId><ArticleId IdType="pubmed">25618350</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue-Dong G, Jing-Fei H, Yue-Dong G, Jing-Fei H. An extension strategy of Discovery Studio 2.0 for non-bonded interaction energy automatic calculation at the residue level. Zoological Res. (2011) 32:262&#x2013;6. doi:&#xa0;10.3724/SP.J.1141.2011.03262</Citation><ArticleIdList><ArticleId IdType="doi">10.3724/SP.J.1141.2011.03262</ArticleId><ArticleId IdType="pubmed">21698791</ArticleId></ArticleIdList></Reference><Reference><Citation>Case DA, Cheatham TE, Darden T, Gohlke H, Luo R, Merz KM, et al. . The amber biomolecular simulation programs. J Comput Chem. (2005) 26:1668. doi:&#xa0;10.1002/JCC.20290</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JCC.20290</ArticleId><ArticleId IdType="pmc">PMC1989667</ArticleId><ArticleId IdType="pubmed">16200636</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham MJ, Murtola T, Schulz R, P&#xe1;ll S, Smith JC, Hess B, et al. . GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. (2015) 1&#x2013;2:19&#x2013;25. doi:&#xa0;10.1016/J.SOFTX.2015.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.SOFTX.2015.06.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C. Comparison of multiple AMBER force fields and development of improved protein backbone parameters. Proteins. (2006) 65:712. doi:&#xa0;10.1002/PROT.21123</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/PROT.21123</ArticleId><ArticleId IdType="pmc">PMC4805110</ArticleId><ArticleId IdType="pubmed">16981200</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant BJ, Rodrigues APC, ElSawy KM, McCammon JA, Caves LSD. Bio3d: an R package for the comparative analysis of protein structures. Bioinformatics. (2006) 22:2695&#x2013;6. doi:&#xa0;10.1093/BIOINFORMATICS/BTL461</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/BIOINFORMATICS/BTL461</ArticleId><ArticleId IdType="pubmed">16940322</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Perez-Sanchez H, XXXC. Lightstone F. A comprehensive docking and MM/GBSA rescoring study of ligand recognition upon binding antithrombin. Curr Top Med Chem. (2017) 17:1631&#x2013;9. doi:&#xa0;10.2174/1568026616666161117112604</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026616666161117112604</ArticleId><ArticleId IdType="pmc">PMC5403970</ArticleId><ArticleId IdType="pubmed">27852201</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;n E, Yang C, Shannon CP, Assadian S, He D, Tebbutt SJ. Cellular and molecular biomarkers of long COVID: a scoping review. EBioMedicine. (2023) 91:104552. doi:&#xa0;10.1016/J.EBIOM.2023.104552</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.EBIOM.2023.104552</ArticleId><ArticleId IdType="pmc">PMC10082390</ArticleId><ArticleId IdType="pubmed">37037165</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyamundanda G, Poudel P, Patil Y, Sadanandam A. A novel statistical method to diagnose, quantify and correct batch effects in genomic studies. Sci Rep 2017 7:1. (2017) 7:1&#x2013;10. doi:&#xa0;10.1038/s41598-017-11110-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-11110-6</ArticleId><ArticleId IdType="pmc">PMC5589920</ArticleId><ArticleId IdType="pubmed">28883548</ArticleId></ArticleIdList></Reference><Reference><Citation>Fricke-Galindo I, Buendia-Roldan I, Chavez-Galan L, P&#xe9;rez-Rubio G, Hern&#xe1;ndez-Zenteno R, de J, et al. . SERPINE1 rs6092 variant is related to plasma coagulation proteins in patients with severe COVID-19 from a tertiary care hospital. Biol (Basel). (2022) 11:595. doi:&#xa0;10.3390/BIOLOGY11040595</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/BIOLOGY11040595</ArticleId><ArticleId IdType="pmc">PMC9029072</ArticleId><ArticleId IdType="pubmed">35453794</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikitopoulou I, Fanidis D, Ntatsoulis K, Moulos P, Mpekoulis G, Evangelidou M, et al. . Increased autotaxin levels in severe covid-19, correlating with il-6 levels, endothelial dysfunction biomarkers, and impaired functions of dendritic cells. Int J Mol Sci. (2021) 22:10006. doi:&#xa0;10.3390/IJMS221810006/S1</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS221810006/S1</ArticleId><ArticleId IdType="pmc">PMC8469279</ArticleId><ArticleId IdType="pubmed">34576169</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill M, Russo S, Olivera D, Malcuori M, Galliussi G, Segovia M. The intracellular cation channel TMEM176B as a dual immunoregulator. Front Cell Dev Biol. (2022) 10:1038429. doi:&#xa0;10.3389/FCELL.2022.1038429</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FCELL.2022.1038429</ArticleId><ArticleId IdType="pmc">PMC9630633</ArticleId><ArticleId IdType="pubmed">36340035</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil R, Chikhale R, Khanal P, Gurav N, Ayyanar M, Sinha S, et al. . Computational and network pharmacology analysis of bioflavonoids as possible natural antiviral compounds in COVID-19. Inform Med Unlocked. (2021) 22:100504. doi:&#xa0;10.1016/J.IMU.2020.100504</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IMU.2020.100504</ArticleId><ArticleId IdType="pmc">PMC7756171</ArticleId><ArticleId IdType="pubmed">33363251</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheurer M, Rodenkirch P, Siggel M, Bernardi RC, Schulten K, Tajkhorshid E, et al. . PyContact: rapid, customizable, and visual analysis of noncovalent interactions in MD simulations. Biophys J. (2018) 114:577&#x2013;83. doi:&#xa0;10.1016/J.BPJ.2017.12.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BPJ.2017.12.003</ArticleId><ArticleId IdType="pmc">PMC5985026</ArticleId><ArticleId IdType="pubmed">29414703</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey D, Hossain R, Biswas P, Paul P, Islam MA, Ema TI, et al. . Amentoflavone derivatives significantly act towards the main protease (3CLPRO/MPRO) of SARS-CoV-2: in silico admet profiling, molecular docking, molecular dynamics simulation, network pharmacology. Mol Divers. (2023) 27:857&#x2013;71. doi:&#xa0;10.1007/S11030-022-10459-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11030-022-10459-9</ArticleId><ArticleId IdType="pmc">PMC9153225</ArticleId><ArticleId IdType="pubmed">35639226</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Lui Y, Yang Y, Zhang P, Zhong W, Wang Y, et al. . Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B. (2020) 10(5):766&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102550</ArticleId><ArticleId IdType="pubmed">32292689</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng M, Zhang S, Dong X, Sun W, Deng Y, Li W, et al. . COVID-19 associated EBV reactivation and effects of ganciclovir treatment. Immun Inflammation Dis. (2022) 10. doi:&#xa0;10.1002/IID3.597</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/IID3.597</ArticleId><ArticleId IdType="pmc">PMC8959425</ArticleId><ArticleId IdType="pubmed">35349757</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Cao S, Dong H, Lv H, Teng X, Zhang J, et al. . Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation. BMC Infect Dis. (2021) 21:1&#x2013;8. doi:&#xa0;10.1186/S12879-021-06638-Y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12879-021-06638-Y</ArticleId><ArticleId IdType="pmc">PMC8441951</ArticleId><ArticleId IdType="pubmed">34525962</ArticleId></ArticleIdList></Reference><Reference><Citation>Manoharan S, Ying LY. Epstein Barr Virus Reactivation during COVID-19 Hospitalization Significantly Increased Mortality/Death in SARS-CoV-2(+)/EBV(+) than SARS-CoV-2(+)/EBV(&#x2013;) Patients: A Comparative Meta-Analysis. Int J Clin Pract. (2023) 2023. doi:&#xa0;10.1155/2023/1068000</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/1068000</ArticleId><ArticleId IdType="pmc">PMC9904914</ArticleId><ArticleId IdType="pubmed">36793928</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H, Zhou X. Bioinformatics analysis of potential common pathogenic mechanisms for COVID-19 infection and primary Sjogren&#x2019;s syndrome. Front Immunol. (2022) 13:938837/BIBTEX. doi:&#xa0;10.3389/FIMMU.2022.938837/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2022.938837/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC9360424</ArticleId><ArticleId IdType="pubmed">35958619</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Z, Yang Y, Li W, Lin Y, Huang W, Zhang S. Exploring key biomarkers and common pathogenesis of seven digestive system cancers and their correlation with COVID-19. Curr Issues Mol Biol. (2023) 45:5515. doi:&#xa0;10.3390/CIMB45070349</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/CIMB45070349</ArticleId><ArticleId IdType="pmc">PMC10378662</ArticleId><ArticleId IdType="pubmed">37504265</ArticleId></ArticleIdList></Reference><Reference><Citation>Jord&#xed;n F, Nguyen TP, Liu WC. Studying protein&#x2013;protein interaction networks: a systems view on diseases. Brief Funct Genomics. (2012) 11:497&#x2013;504. doi:&#xa0;10.1093/BFGP/ELS035</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/BFGP/ELS035</ArticleId><ArticleId IdType="pubmed">22908210</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugourd A, Saez-Rodriguez J. Footprint-based functional analysis of multiomic data. Curr Opin Syst Biol. (2019) 15:82&#x2013;90. doi:&#xa0;10.1016/J.COISB.2019.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.COISB.2019.04.002</ArticleId><ArticleId IdType="pmc">PMC7357600</ArticleId><ArticleId IdType="pubmed">32685770</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto K. Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein&#x2013;Barr virus and the gut&#x2013;brain axis. Mol Psychiatry 2023. (2023) 28:1&#x2013;9. doi:&#xa0;10.1038/s41380-023-02161-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02161-5</ArticleId><ArticleId IdType="pmc">PMC11041741</ArticleId><ArticleId IdType="pubmed">37402856</ArticleId></ArticleIdList></Reference><Reference><Citation>Mengyan X, Kun D, Xinming J, Yutian W, Yongqian S. Identification and verification of hub genes associated with the progression of non-small cell lung cancer by integrated analysis. Front Pharmacol. (2022) 13:997842/FULL. doi:&#xa0;10.3389/FPHAR.2022.997842/FULL</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FPHAR.2022.997842/FULL</ArticleId><ArticleId IdType="pmc">PMC9513139</ArticleId><ArticleId IdType="pubmed">36176446</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, D&#x2019;abrosca G, Antolak A, Pedone PV, Isernia C, Malgieri G. Host and viral zinc-finger proteins in COVID-19. Int J Mol Sci. (2022) 23, 3711. doi:&#xa0;10.3390/IJMS23073711</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS23073711</ArticleId><ArticleId IdType="pmc">PMC8998646</ArticleId><ArticleId IdType="pubmed">35409070</ArticleId></ArticleIdList></Reference><Reference><Citation>Tune CE, Pilon M, Saiki Y, Dosch H-M. Sustained expression of the novel EBV-induced zinc finger gene, ZNFEB, is critical for the transition of B lymphocyte activation to oncogenic growth transformation. J Immunol. (2002) 168:680&#x2013;8. doi:&#xa0;10.4049/JIMMUNOL.168.2.680</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/JIMMUNOL.168.2.680</ArticleId><ArticleId IdType="pubmed">11777961</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorley-Lawson DA. EBV persistence&#x2014;Introducing the virus. Curr Top Microbiol Immunol. (2015) 390:151. doi:&#xa0;10.1007/978-3-319-22822-8_8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-22822-8_8</ArticleId><ArticleId IdType="pmc">PMC5125397</ArticleId><ArticleId IdType="pubmed">26424647</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin W, Yip YL, Jia L, Deng W, Zheng H, Dai W, et al. . Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma. Nat Commun. (2018) 9:1&#x2013;17. doi:&#xa0;10.1038/s41467-018-06889-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06889-5</ArticleId><ArticleId IdType="pmc">PMC6220246</ArticleId><ArticleId IdType="pubmed">30405107</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon-Lowe C, Rickinson A. The global landscape of EBV-associated tumors. Front Oncol. (2019) 9:713. doi:&#xa0;10.3389/FONC.2019.00713</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FONC.2019.00713</ArticleId><ArticleId IdType="pmc">PMC6691157</ArticleId><ArticleId IdType="pubmed">31448229</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR, et al. . Distinguishing features of Long COVID identified through immune profiling. Nature. (2023) 623.7985:139&#x2013;48. doi:&#xa0;10.1101/2022.08.09.22278592</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. (2022) 110, 3484. doi:&#xa0;10.1016/J.NEURON.2022.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NEURON.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133. doi:&#xa0;10.1038/S41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Xia Z, Wan Y, Huang P. Identification of hub genes and candidate drugs in hepatocellular carcinoma by integrated bioinformatics analysis. Medicine. (2021) 100:E27117. doi:&#xa0;10.1097/MD.0000000000027117</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000027117</ArticleId><ArticleId IdType="pmc">PMC8483840</ArticleId><ArticleId IdType="pubmed">34596112</ArticleId></ArticleIdList></Reference><Reference><Citation>Schimke LF, Marques AHC, Baiocchi GC, Prado CA, de S, Fonseca DLM, et al. . Severe COVID-19 shares a common neutrophil activation signature with other acute inflammatory states. Cells. (2022) 11:847. doi:&#xa0;10.3390/CELLS11050847/S1</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/CELLS11050847/S1</ArticleId><ArticleId IdType="pmc">PMC8909161</ArticleId><ArticleId IdType="pubmed">35269470</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Shah S. Structure-based virtual screening. Methods Mol Biol. (2017) 1558:111&#x2013;24. doi:&#xa0;10.1007/978-1-4939-6783-4_5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-6783-4_5</ArticleId><ArticleId IdType="pubmed">28150235</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Wang J, Fan JH, Zhang YQ, Zhao JX, Dai XJ, et al. . Ilexgenin A exerts anti-inflammation and anti-angiogenesis effects through inhibition of STAT3 and PI3K pathways and exhibits synergistic effects with Sorafenib on hepatoma growth. Toxicol Appl Pharmacol. (2017) 315:90&#x2013;101. doi:&#xa0;10.1016/J.TAAP.2016.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.TAAP.2016.12.008</ArticleId><ArticleId IdType="pubmed">27986624</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhowmik A, Biswas S, Hajra S, Saha P. In silico validation of potent phytochemical orientin as inhibitor of SARS-CoV-2 spike and host cell receptor GRP78 binding. Heliyon. (2021) 7. doi:&#xa0;10.1016/J.HELIYON.2021.E05923</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.HELIYON.2021.E05923</ArticleId><ArticleId IdType="pmc">PMC7799170</ArticleId><ArticleId IdType="pubmed">33458435</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Chen DY, Scartelli C, Xie H, Merrill-Skoloff G, Yang M, et al. . Plant flavonoid inhibition of SARS-CoV-2 main protease and viral replication. iScience. (2023) 26:107602. doi:&#xa0;10.1016/J.ISCI.2023.107602</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ISCI.2023.107602</ArticleId><ArticleId IdType="pmc">PMC10470319</ArticleId><ArticleId IdType="pubmed">37664626</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan H, He J, Yang Z, Yao X, Zhang H, Li R, et al. . Myricetin possesses the potency against SARS-CoV-2 infection through blocking viral-entry facilitators and suppressing inflammation in rats and mice. Phytomedicine. (2023) 116:154858. doi:&#xa0;10.1016/J.PHYMED.2023.154858</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PHYMED.2023.154858</ArticleId><ArticleId IdType="pmc">PMC10162847</ArticleId><ArticleId IdType="pubmed">37224774</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD. Molecular docking and structure-based drug design strategies. Molecules. (2015) 20:13384&#x2013;421. doi:&#xa0;10.3390/MOLECULES200713384</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/MOLECULES200713384</ArticleId><ArticleId IdType="pmc">PMC6332083</ArticleId><ArticleId IdType="pubmed">26205061</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitusi&#x144;ska K, Skalski T, G&#xf3;ra A. Simple selection procedure to distinguish between static and flexible loops. Int J Mol Sci. (2020) 21. doi:&#xa0;10.3390/IJMS21072293</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS21072293</ArticleId><ArticleId IdType="pmc">PMC7177474</ArticleId><ArticleId IdType="pubmed">32225102</ArticleId></ArticleIdList></Reference><Reference><Citation>Galdadas I, Qu S, Oliveira ASF, Olehnovics E, Mack AR, Mojica MF, et al. . Allosteric communication in class A &#x3b2;-lactamases occurs via cooperative coupling of loop dynamics. Elife. (2021) 10. doi:&#xa0;10.7554/ELIFE.66567</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/ELIFE.66567</ArticleId><ArticleId IdType="pmc">PMC8060031</ArticleId><ArticleId IdType="pubmed">33755013</ArticleId></ArticleIdList></Reference><Reference><Citation>Varma AK, Patil R, Das S, Stanley A, Yadav L, Sudhakar A. Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PloS One. (2010) 5. doi:&#xa0;10.1371/JOURNAL.PONE.0012029</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0012029</ArticleId><ArticleId IdType="pmc">PMC2922327</ArticleId><ArticleId IdType="pubmed">20808434</ArticleId></ArticleIdList></Reference><Reference><Citation>Majewski M, Ruiz-Carmona S, Barril X. An investigation of structural stability in protein-ligand complexes reveals the balance between order and disorder. Commun Chem. (2019) 2:1&#x2013;8. doi:&#xa0;10.1038/s42004-019-0205-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42004-019-0205-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Hata H, Tran DP, Sobeh MM, Kitao A, Sobeh MM. Binding free energy of protein/ligand complexes calculated using dissociation Parallel Cascade Selection Molecular Dynamics and Markov state model. Biophys Physicobiol. (2021) 18:305. doi:&#xa0;10.2142/BIOPHYSICO.BPPB-V18.037</Citation><ArticleIdList><ArticleId IdType="doi">10.2142/BIOPHYSICO.BPPB-V18.037</ArticleId><ArticleId IdType="pmc">PMC8694779</ArticleId><ArticleId IdType="pubmed">35178333</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>